ES2128562T3 - Celulas deficientes en sialidasa. - Google Patents

Celulas deficientes en sialidasa.

Info

Publication number
ES2128562T3
ES2128562T3 ES94916789T ES94916789T ES2128562T3 ES 2128562 T3 ES2128562 T3 ES 2128562T3 ES 94916789 T ES94916789 T ES 94916789T ES 94916789 T ES94916789 T ES 94916789T ES 2128562 T3 ES2128562 T3 ES 2128562T3
Authority
ES
Spain
Prior art keywords
sialidase
dna
sialidasa
deficient cells
arn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94916789T
Other languages
English (en)
Inventor
Thomas G Warner
Mary B Sliwkowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2128562T3 publication Critical patent/ES2128562T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

UN LINEA CELULAR RECOMBINANTE QUE TIENE UNA SIALIDASA CONSTITUTIVA CUYA EXPRESION FUNCION QUEDA INTERRUMPIDA MEDIANTE, POR EJEMPLO, UNA RECOMBINACION HOMOLOGA O MEDIANTE LA UTILIZACION DE UN ARN ANTISENTIDO. LA SIALIDASA SE PURIFICA A PARTIR DEL FLUIDO DE UN CULTIVO DE CELULAS DE CELULAS DE LOS OVARIOS DE HAMSTERES CHINOS. EL ADN QUE CODIFICA LA SIALIDASA SE PUEDE OBTENER UTILIZANDO UNA SONDA DE OLIGONUCLEOTIDOS DISEÑADA UTILIZANDO LOS DATOS DE UNA SECUENCIA DE AMINOACIDOS SOBRE LA SIALIDASA Y EL ADN SE EXPRESA EN LAS CELULAS HUESPEDES TRANSFORMADAS CON EL ADN.
ES94916789T 1993-05-17 1994-05-17 Celulas deficientes en sialidasa. Expired - Lifetime ES2128562T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6258693A 1993-05-17 1993-05-17
US18732794A 1994-01-25 1994-01-25

Publications (1)

Publication Number Publication Date
ES2128562T3 true ES2128562T3 (es) 1999-05-16

Family

ID=26742448

Family Applications (2)

Application Number Title Priority Date Filing Date
ES94916789T Expired - Lifetime ES2128562T3 (es) 1993-05-17 1994-05-17 Celulas deficientes en sialidasa.
ES98106858T Expired - Lifetime ES2346941T3 (es) 1993-05-17 1994-05-17 Sialidasa recombinante de celula cho.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES98106858T Expired - Lifetime ES2346941T3 (es) 1993-05-17 1994-05-17 Sialidasa recombinante de celula cho.

Country Status (13)

Country Link
US (1) US5928915A (es)
EP (2) EP0866130B1 (es)
JP (1) JPH08510133A (es)
AT (2) ATE474925T1 (es)
AU (2) AU6834994A (es)
CA (1) CA2160458A1 (es)
DE (2) DE69415669T2 (es)
DK (2) DK0866130T3 (es)
ES (2) ES2128562T3 (es)
GR (1) GR3029781T3 (es)
NZ (1) NZ266714A (es)
PT (1) PT866130E (es)
WO (1) WO1994026908A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562588B2 (en) * 1993-05-17 2003-05-13 Genentech, Inc. Sialidase and recombinant cell lines
JP3088681B2 (ja) * 1997-05-22 2000-09-18 宮城県 形質膜局在シアリダーゼ及びそれをコードするｄｎａ
US6261805B1 (en) * 1999-07-15 2001-07-17 Boyce Thompson Institute For Plant Research, Inc. Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
KR100604258B1 (ko) * 1999-12-30 2006-07-31 씨제이 주식회사 당단백질의 생체내 활성을 증가시키는 방법
AU2002222436A1 (en) * 2001-12-14 2003-06-30 Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A reporter gene
EP1711512B1 (en) * 2004-01-30 2012-01-11 Amgen Inc. Process for purifying proteins
WO2007108464A1 (ja) * 2006-03-20 2007-09-27 Kyowa Hakko Kogyo Co., Ltd. 哺乳動物由来細胞質シアリダーゼに対する抗体
CA2676686C (en) * 2007-02-20 2015-12-15 Dsm Ip Assets B.V. Novel sialidase
JP4772905B2 (ja) 2007-04-02 2011-09-14 協和発酵キリン株式会社 アンチトロンビン組成物の製造方法
EP2930245B1 (en) * 2007-10-12 2017-11-22 Sigma-Aldrich Co. LLC Cell line and methods for improved glycoprotein sialylation
JP2008263996A (ja) * 2008-06-02 2008-11-06 National Institute Of Advanced Industrial & Technology 発光甲虫由来赤色発光酵素安定体の生産及び精製法
US11060083B2 (en) 2013-07-19 2021-07-13 Larix Bioscience Llc Methods and compositions for producing double allele knock outs
JP6482546B2 (ja) * 2013-07-19 2019-03-13 ラリクス・バイオサイエンス・リミテッド・ライアビリティ・カンパニーＬａｒｉｘ Ｂｉｏｓｃｉｅｎｃｅ， Ｌｌｃ 二重対立遺伝子ノックアウトを生成するための方法および組成物
CN120904322A (zh) 2013-09-13 2025-11-07 豪夫迈·罗氏有限公司 包含纯化的重组多肽的方法和组合物
RU2016107435A (ru) 2013-09-13 2017-10-18 Дженентек, Инк. Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты
CN114258431A (zh) * 2019-07-03 2022-03-29 帕利昂制药有限公司 重组人唾液酸酶、唾液酸酶融合蛋白及其使用方法
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912040A (en) * 1986-11-14 1990-03-27 Genetics Institute, Inc. Eucaryotic expression system
US5075218A (en) * 1987-12-29 1991-12-24 Biomira, Inc. Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof
US5047335A (en) * 1988-12-21 1991-09-10 The Regents Of The University Of Calif. Process for controlling intracellular glycosylation of proteins
WO1993010260A1 (en) * 1991-11-21 1993-05-27 The Board Of Trustees Of The Leland Stanford Junior University Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases

Also Published As

Publication number Publication date
GR3029781T3 (en) 1999-06-30
EP0700443B1 (en) 1998-12-30
ES2346941T3 (es) 2010-10-21
DE69435304D1 (de) 2010-09-02
EP0866130B1 (en) 2010-07-21
EP0700443A1 (en) 1996-03-13
PT866130E (pt) 2010-10-26
DE69415669T2 (de) 1999-07-01
AU7841998A (en) 1998-10-01
EP0866130A1 (en) 1998-09-23
US5928915A (en) 1999-07-27
NZ266714A (en) 1997-12-19
WO1994026908A1 (en) 1994-11-24
DK0866130T3 (da) 2010-10-04
ATE175239T1 (de) 1999-01-15
DK0700443T3 (da) 1999-08-30
JPH08510133A (ja) 1996-10-29
DE69415669D1 (de) 1999-02-11
CA2160458A1 (en) 1994-11-24
AU6834994A (en) 1994-12-12
ATE474925T1 (de) 2010-08-15

Similar Documents

Publication Publication Date Title
ES2128562T3 (es) Celulas deficientes en sialidasa.
ES2151463T1 (es) Constructos de adn para la modificacion de la activacion y expresion de genes endogenos.
ES2110447T3 (es) Sistema de afeitado.
AR069653A2 (es) Variante de glucoamilasa original de aspergillus, una construccion de adn, un vector de expresion recombinante, una celula, un proceso para convertir almidon, uso de una variante de glucoamilasa para un proceso de la fermentacion y metodo para alterar la estabilidad termica.
DK639689D0 (da) Indfoering af dna i celler
BR9813608B1 (pt) célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase.
DE69133228D1 (de) Dna-expressionssysteme basierend auf alphaviren
ES2148323T3 (es) Sistema de expresion de un gen a base de geminivirus.
ATE234637T1 (de) Verbesserungen von oder in bezug auf endometrialfunktion
ES2184252T3 (es) Derivados fenilos trisustituidos con una actividad biologica de tipo agonista retinoide, antagonista o agonista inverso.
KR880700856A (ko) 조직 플라스미노겐 활성화인자(tpa)상사체
NO863666D0 (no) Vaeskeformete sanitaerrengjoerings- og avkalkingsmiddel, samt fremgangsmaate til fremstilling derav.
ES2166394T3 (es) Linea celular indicadora y procedimiento para detectar virus de rna.
FI852024L (fi) Jaestvektor.
AR246983A1 (es) Plasmido dna recombinante, linea celular y procedimiento para producir beta-ngf humano.
NO952039L (no) Proteiner med glykosyltransferase-aktivitet
DK388789A (da) Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna
ES2187504T3 (es) Vectores no oncovirales, basados en el vmmp, con encapsidacion defectuosa.
ES2118827T3 (es) Procedimiento y medio de cultivo celular para el cultivo de celulas animales adherentes.
DE59405120D1 (de) Verfahren zum screenen von substanzen mit modulierender wirkung auf einen interleukin-5-rezeptor-abhängigen zellulären signalübertragungsweg
DE69427857D1 (de) Markiergen
PE104999A1 (es) Nuevo marcador de seleccion
EP0785716A4 (en) CYTOKIN DESCRIBED AS LERK6
NO870948L (no) Vektor, samt fremgangsmŸte for frembringelse av en transformert cellelinje med hŸyt ekspresjonsnivŸ.
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 700443

Country of ref document: ES